TherDose Pharma, 19 years young knowledge based pharmaceutical company with a specialization in oncology. We aim to develop differentiated products across a wide spectrum of various therapeutic areas utilizing rigorous scientific principle.
Our strong in-house R&D is well versed in development of complex drug molecules across the domain that allows us to serve pharmaceutical needs of diversified markets worldwide.
TherDose has developed more than 35 Generics and specialty drugs to various global clientele. 40 dossiers have been filed across 25 countries of Emerging Market. 50+ generic dossiers been supported for filing with emerging markets in the oncology therapeutic area.